
Michael McKenna
Queensland Editor at The Australian
Journalist at The Australian newspaper. [email protected]
Articles
-
1 week ago |
washingtontimes.com | Michael McKenna
OPINION: In the wake of an election, it is always tempting to conclude that the winning side will advance from victory to victory and all its efforts will result in unalloyed achievements of its policies. Before last week, we were at that moment in the ascendancy of President Trump and his team. They seemed invincible. Then the bond market showed up with those three dozen or so House Republicans who may care more about reducing spending than they do about tax reform.
-
1 week ago |
margolisedelstein.com | Michael McKenna
New Jersey Supreme Court Affirms Commissions Are Wages Under the Wage Payment LawDoes Pennsylvania Law Allow Employers to Reverse a Mistaken Acceptance of a Workers’ Compensation Claim? Motion to Dismiss Granted in Virginia Motor Vehicle Accident CaseSummary Judgment Granted in Complex Construction Defect Case
-
2 weeks ago |
theaustralian.com.au | Greg Sheridan |Michael McKenna |Lydia Lynch |Henry Ergas
Funding to support Phase III clinical trials for diabetic foot infections and acute bacterial skin and skin structure infectionsPrivate Australian-based investor has subscribed for $5 million shares via a placementA$10.8 million entitlement offer has been launched at $0.28 per shareSpecial Report: Targeting first revenue in 2026, Recce will use new funds of up to $15.8m to support a Phase III registrational topical clinical trial for its diabetic foot infection (DFI) treatment in Indonesia.
-
2 weeks ago |
science.org | Yongyong Yang |Shijing Liang |Moriah R. Arnold |Michael McKenna
MATERIALS AND METHODSpX459 (Addgene, 62988) and guide RNA (gRNA)–AAVS1–T2 (Addgene, 41818), pOG44 (Invitrogen, V600520), pHDM-G (PlasmID, EvNO00061606), pHDM-HGPM2 (PlasmID, EvNO00061607), pHDM-tat1B (PlasmID, EvNO00061608), and pRC-CMV-rev1B (PlasmID, EvNO00061616) were obtained from the indicated suppliers. pDEST-hisMBP-AsCpf1-EC (Addgene, 79009) was modified to remove the maltose binding protein (MBP) sequence using standard molecular biology techniques.
-
2 weeks ago |
washingtontimes.com | Michael McKenna
OPINION: A lot of people are concerned about the president’s tariffpalooza. It won’t work. It can’t work. It isn’t working. There is no way to change the irresistible forces of international capital flows. The idea of bringing back American manufacturing is a mirage only fools entertain. The market is cratering. We are hurtling toward an economic reckoning unless we reverse course.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 1K
- DMs Open
- No

RT @MurrayWatt: Oh hello. https://t.co/N183Sm7WMW

RT @QuentinDempster: We mourn the death of Matt Peacock, the great ABC radio and TV broadcaster and investigative journalist. Matt has died…

RT @sarahelksqld: The final Feeding the Chooks before the Queensland election is up! #qldpol #qldvotes @McKennaattheOz @LydiaLynch101 @Ma…